LINC02833

Across TCGA pan-cancer cohorts, LINC02833 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC02833’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where LINC02833 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02833 is over-expressed in tumor, although a few such as LUSC show the opposite, repressed pattern.

BRCA and LUSC are the cancer types where LINC02833 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02833 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	II,III,IV	+0.009	.003	4	view →
LUSC	Female	II,III,IV	−0.020	.025	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

LINC02833–BRCA

Open the BRCA breakdown →